Systematic reviews and meta-analyses: When they are useful and when to be careful

Kidney International

Volumn 76, Issue 11, 2009, Pages 1130-1136

  Noordzij, Marlies ^a   Hooft, Lotty ^b   Dekker, Friedo W ^c   Zoccali, Carmine ^d   Jager, Kitty J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CNR Consiglio Nazionale delle Ricerche   (Italy)

Author keywords

Epidemiology; Meta analysis; QUORUM statement; Statistics; Systematic review

Indexed keywords

CHRONIC KIDNEY DISEASE; CLINICAL RESEARCH; DATA ANALYSIS; DATA EXTRACTION; HUMAN; INFORMATION RETRIEVAL; MEDICAL INFORMATION; MEDICAL LITERATURE; META ANALYSIS; METHODOLOGY; PRIORITY JOURNAL; PUBLICATION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICS; SYSTEMATIC REVIEW;

EID: 72949117009     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.339     Document Type: Article

References (27)

1. Cook DJ, Sackett DL, Spitzer WO. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol 1995; 48: 167-171.
2. Strippoli GF, Navaneethan SD, Johnson DW et al. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ 2008; 336: 645-651.
3. Richardson WS, Wilson MC, Nishikawa J et al. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995; 123: A12-A13.
4. Wildridge V, Bell L. How CLIP became ECLIPSE: a mnemonic to assist in searching for health policy/ management information. Health Info Libr J 2002; 119: 113-115. http://medline.cos.com/.
5. Moher D, Jadad AR, Nichol G et al. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995; 16: 62-73. http://www.cochrane.org/.
6. Webster A, Woodroffe RC, Taylor RS et al. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev 2005 CD003961.
7. Stel VS, Jager KJ, Zoccali C et al. The randomized clinical trial: an unbeatable standard in clinical research? Kidney Int 2007; 72: 539-542.
8. Jager KJ, Zoccali C, Macleod A et al. Confounding: what it is and how to deal with it. Kidney Int 2008; 73: 256-260.
9. Tonelli M, James M, Wiebe N et al. Ultrasound monitoring to detect access stenosis in hemodialysis patients: a systematic review. Am J Kidney Dis 2008; 51: 630-640.
10. Chan MR, Dall AT, Fletcher KE et al. Outcomes in patients with chronic kidney disease referred late to nephrologists: a meta-analysis. Am J Med 2007; 120: 1063-1070.
11. Wang Y, Chen X, Song Y et al. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 2008; 73: 19-33. (Pubitemid 350273639)
12. Moher D, Cook DJ, Eastwood S et al. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354: 1896-1900.
13. Shea BJ, Grimshaw JM, Wells GA et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007; 7: 10.
14. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285: 1987-1991. (Pubitemid 32366951)
15. Moher D, Schulz KF, Altman D. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. Explore 2005; 1: 40-45.
16. Palmer SC, McGregor DO, Macaskill P et al. Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 2007; 147: 840-853.
17. Lau J, Ioannidis JP, Schmid CH. Summing up evidence: one answer is not always enough. Lancet 1998; 351: 123-127.
18. Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
20. Tripepi G, Jager KJ, Dekker FW et al. Bias in clinical research. Kidney Int 2008; 73: 148-153.
21. Easterbrook PJ, Berlin JA, Gopalan R et al. Publication bias in clinical research. Lancet 1991; 337: 867-872.
22. Dwan K, Altman DG, Arnaiz JA et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS ONE 2008; 3: e3081.
23. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 2001; 323: 101-105.
24. Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006; 333: 420-423. http://www.who.int/ictrp/en/.
25. Shojania KG, Sampson M, Ansari MT et al. How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med 2007; 147: 224-233.
26. Moher D, Tsertsvadze A, Tricco AC et al. A systematic review identified few methods and strategies describing when and how to update systematic reviews. J Clin Epidemiol 2007; 60: 1095-1104.
27. Sutton AJ, Donegan S, Takwoingi Y et al. An encouraging assessment of methods to inform priorities for updating systematic reviews. J Clin Epidemiol 2009; 62: 241-251.